Table 1.
Case | Age (years) | Gender | Initial VA | Time to correct diagnosis (weeks) | Aqueous PCR result | Presence of RD | Orbital findings | Final VA | Interval between presentation and final follow-up (months) |
---|---|---|---|---|---|---|---|---|---|
Yaman et al.7 | 25 | F | CF | 1 | N/A | + | Diffuse inflammation | 20/400 | 6 |
Foo et al.8 | 30 | F | 20/80 | 3 | HSV-1 | – | Diffuse inflammation, EOM restriction | NLP | 3 |
Tornerup et al.9 | 34 | F | 20/25 | 1 | HSV-1 | + | Proptosis, diffuse inflammation | NLP | 3 |
Rozenbaum et al.10 | 49 | F | HM | 0 | HSV-2 | + | Myositis | NLP | 2 |
Badilla et al.11 | 81 | F | HM | 0 | N/A | – | Proptosis, myositis | 20/25 | 1 |
Case 1 | 73 | M | HM | 4 | HSV-2 | + | Diffuse inflammation, posterior scleritis | LP | 20 |
Case 2 | 18 | F | HM | 1 | HSV-1 | – | Diffuse inflammation, dacryoadenitis | 20/80 | 6 |
PCR = polymerase chain reaction; RD = retinal detachment; VA = visual acuity; CF = count fingers; HM = hand motion; NLP = no light perception; N/A = not applicable.